학술논문

p53 autoantibodies, cytokine levels and ovarian carcinogenesis
Document Type
Report
Source
Gynecologic Oncology. July, 2009, Vol. 114 Issue 1, p12, 6 p.
Subject
Autoimmunity
Tumor proteins
Autoantibodies
Immunity
Language
English
ISSN
0090-8258
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ygyno.2009.03.028 Byline: Miyun Tsai-Turton (a), Antonio Santillan (a)(b), Dan Lu (a), Robert E. Bristow (b), Kwun C. Chan (c)(d), Ie-Ming Shih (a)(b), Richard B.S. Roden (a)(b) Keywords: Ovarian cancer; p53; Autoantibody; Tumor-associated antigen; Cytokine Abbreviations: TAA, tumor-associated antigen; AAb, autoantibody; T, tumor-infiltrating lymphocytes Abstract: To address the hypothesis that type II ovarian carcinoma, mutation of p53 and plasma levels of particular cytokines are associated with the generation of p53-specific serum autoantibody (AAb) responses in patients. Author Affiliation: (a) Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA (b) Gynecology and Obstetrics and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA (c) Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, MD, USA (d) Department of Biostatistics, University of Washington, Seattle, WA, USA Article History: Received 10 February 2009